Literature DB >> 17591568

Radiotherapy of hodgkin lymphoma: indications, new fields, and techniques.

Theodore Girinsky1, Mithra Ghalibafian.   

Abstract

In recent years, radiotherapy in patients with Hodgkin lymphoma has evolved considerably because of sophisticated imaging technologies and radiation delivery techniques. Even more recently, a new radiation field concept has emerged to ensure better normal tissue protection while preserving an excellent clinical outcome. The role of radiation therapy is also rapidly changing because the concept of a risk-adapted treatment strategy, in which combined-modality treatments were the order of the day, is now expanding into a concept of response-adapted treatments.

Entities:  

Mesh:

Year:  2007        PMID: 17591568     DOI: 10.1016/j.semradonc.2007.02.007

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  10 in total

1.  Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.

Authors:  Youlia M Kirova; Cyrus Chargari
Journal:  World J Radiol       Date:  2011-03-28

2.  Cardiac surgery in patients irradiated for Hodgkin's lymphoma.

Authors:  S Siregar; F de Heer; L A van Herwerden
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

3.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

Review 4.  The concept and evolution of involved site radiation therapy for lymphoma.

Authors:  Lena Specht; Joachim Yahalom
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

Review 5.  Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.

Authors:  Stephanie A Terezakis; Yvette L Kasamon
Journal:  Crit Rev Oncol Hematol       Date:  2012-03-29       Impact factor: 6.312

6.  Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.

Authors:  Eva Holzhäuser; Maximilian Berlin; Daniel Wollschläger; Thomas Bezold; Arnulf Mayer; Georg Heß; Heinz Schmidberger
Journal:  Strahlenther Onkol       Date:  2017-07-26       Impact factor: 3.621

7.  Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies.

Authors:  Matthew Koshy; Shayna E Rich; Usama Mahmood; Young Kwok
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-27       Impact factor: 7.038

8.  A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.

Authors:  Stephanie A Terezakis; Heiko Schöder; Alexander Kowalski; Patrick McCann; Remy Lim; Alla Turlakov; Mithat Gonen; Chris Barker; Anuj Goenka; Shona Lovie; Joachim Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-11       Impact factor: 7.038

9.  Adjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study.

Authors:  Hayoon Lee; Jun Won Kim; Sung Joon Hong; Seung Choul Yang; Young Deuk Choi; Koon Ho Rha; Jaeho Cho
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

10.  Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.

Authors:  Delphine Antoni; Shanti Natarajan-Ame; Philippe Meyer; Claudine Niederst; Khalil Bourahla; Georges Noel
Journal:  Radiat Oncol       Date:  2013-05-02       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.